Skip to main content

Table 1 Establishment of Vaccine Priority Groups in EUA and GSHAGB countries

From: Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review

Countries Source(s) data abstraction included in this review No. of main groups Presence of list of subgroups within 3 main groups (Table 2) Ranking of groups Ethic committees/consultant involved Intention to vaccinate whole populationC Pandemic vaccine priority groupsD
  Pandemic plan Email fax Phone       (1) Healthcare workers (2) Essential service providers (3) High risk individuals (4) Healthy adults and childrenE Other (Table 3) F
ATA yes yes yes 3 no1a no yes1b yes yes yes yes no no
BEA yes yes yes discussion not applicable not applicable no unknown      
BGA yes yes no 3 yes yes noI yes3 yes yes yes yes no
CAB,2 yes yes no 5H yes yes noI yes yes yes yes yes no
CYA noG yes no 5H unknown yes yes yes partly4 yes yes yes no
CZA, yes yes5 no 3 yes unknown unknown unknown yes yes yes no no
DKA,6 yes yes yes 7H yes yes, 2 groups6 no yes yes yes yes yesJ no
EEA yes yes no 3 yes yes noI yes yes yes yes partlyK yes
FIA,7 noG yes no 17 unknown yes, 1 group7 yes yes yes7 no7 no7 no no
FRA,B,8 yes yes yes 3 no no no unknown yes yes yes no no
DEA,B yes yes yes 29a no9b yes no yes yes yes no no no
GRA,10 yes yes no 510 unknown discussion10 yes unknown yes10 yes10 yes10 no yes10
HUA yes yes no 3 no yes no yes yes yes yes no no
IEA yes yes no 7H yes yes noI yes yes yes yes yesJ yes
ITA,B yes yes no 6H yes yes no yes yes yes yes yes yes
JPB,11 yes yes yes 6H discussion discussion no yes yes yes yes yes yes
LVA,12 noG yes no 012 not applicable not applicable unknown unknown      
LTA,13 yes yes no 4 yes discussion no yes yes yes yes no no
LUA yes no yes 0 not applicable not applicable unknown unknown      
MTA no14a yes no 8H14b no yes no yes yes yes yes yes yes
MXB,15 noG yes no 0 not applicable not applicable yes unknown      
POA,16 yes yes no 2 yes no unknown unknown yes yes yes partlyK no
PTA noG yes no discussion unknown discussion yes yes      
ROA noG yes no 5 yes yes yes unknown yes yes yes partlyK yes
SKA yes yes no 4 yes no no unknown yes yes yes no yes
SIA noG yes no 4 no yes noI unknown yes yes yes partlyK no
ESA yes yes no 4H discussion yes no discussion yes yes yes yes no
SEA yes yes no 7H no no yes yes yes yes yes yes yes
NLA yes yes yes 4H yes yes no yes yes no yes yes no
UKA,B,17 yes yes no 7H yes yes yes yes yes yes yes yesJ yes
USB,18 yes no yes 4H yes yes yes yes yes yes yes yes yes
Summary 23/31 (74%) 29/31 (94%) 9/31 (29%) 26/31 (84%) 14/26 (54%) 17/26 (65%) 10/31 (32%) 19/31 (61%) 26/26 (100%) 24/26 (92%) 24/26 (92%) 13/26 (50%) 11/26 (42%)
  1. A Member State of European Union (EU); B Member of Global Health Security Action Group (GSHAG); C 'yes'indicates that either National Pandemic Plan specifically reports the aim to vaccinate whole population and/or National Pandemic Plan includes 'healthy adults and children' as one of the vaccine priority group(s) and/or country representatives specifically reported this information; 'discussion' indicates country representative specifically reported that vaccination policy is still under discussion, 'unknown' indicates that this item is not specifically reported; D The issue of prioritisation arises only in the situation of vaccine shortage or when vaccines become available over time; E 'yes refers to those countries either specifying 'healthy adults and children' as vaccine priority group(s) and those countries reporting 'offer to all' as vaccine priority group; F Vaccine priority groups that could not be categorized in the four most common vaccine priority groups as described in this table; G National Pandemic Plan available in public domain in language other than English, Danish, Dutch, French, German or Swedish; H Including a category referring to vaccination of whole population; I Ethics considerations will be involved in the future; J Included under the vaccine priority group 'offer to all'; K Countries have included 'children' under 'high risk individuals'
  2. 1a (AT) National Pandemic Plan serves as a framework to guide each of the nine states to develop specific plan including vaccine priority subgroups; 1b No specific ethical committee involved but ethical considerations have been involved;
  3. 2 (CA) Advancements in knowledge and technology are currently being considered by the Pandemic Vaccine Working group and may result in the revision of vaccine priority groups in updated Pandemic Plan in 2007
  4. 3 (BG) Specified in draft national influenza preparedness plan of Bulgaria as "aim is to cover gradually the maximum part of the population";
  5. 4 (CY) Specified as people working in the Health Sector involved with the distribution of vaccines and antivirals;
  6. 5 (CZ) Information received by email is from the unpublished National Pandemic Plan of the Czech Republic 2006;
  7. 6 (DK) Prioritisation of vaccine strategies will be decided during the course of a pandemic, the information in the table reflects the discussion paper in the pandemic plan;
  8. 7 (FI) Irrespective of the virus one vaccine priority group is determined in advance;
  9. 8 (FR) Working groups are updating strategies using pre-pandemic modelling but also accurate survey of the population and age-groups most affected by virus, associated with models of progressive availability of the vaccine in relation with the kinetics of a pandemic will determine the vaccine priority groups;
  10. 9a (DE) Two main vaccine priority groups have been determined, discussion related to criteria of establishing further vaccine priority groups are under discussion 9b National Plan serves as a framework to guide each of the 16 states to develop specific plan including vaccine priority subgroups.
  11. 10 (GR) Is in the process of discussing and further refining vaccine priority groups, the information in the table includes "suggested priority groups" as published in National Pandemic Plan;
  12. 11 (JP) Prioritisation is under discussion and the table includes information in draft guidelines available for public discussion and comments;
  13. 12 (LV) Influenza Pandemic Preparedness Plan of Latvia will be updated in 2007;
  14. 13 (LT) Vaccine priority groups will be revised in the "near future" [as of October 26th 2006];
  15. 14a (MT) National Influenza Pandemic Standing Committee has decided on vaccine priority groups and currently the plan prepared by this committee is being approved and amended by the Director General; 14b Seven of eight reported vaccine priority groups have been categorized under four main categories included in this table;
  16. 15 (MX) Current National Preparedness and Response Plans does not include a scenario in which pandemic vaccine is available; this aspect may be updated as information on vaccine production and availability becomes available.
  17. 16 (PL) More specific and detailed strategy under discussion;
  18. 17 (UK) Plan is currently under revision, including more modelling of immunisation strategies;
  19. 18 (US) Revision of order prioritisation of tiers is expected in spring 2007.